News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-20 9:33:7 am Taysha: Initial Rett Syndrome Data Leads To Other 2024 Catalysts SeekingAlpha
2024-03-15 1:5:0 pm Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
2024-03-13 1:5:0 pm Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day Business Wire
2024-03-12 1:8:49 pm Acadia Hits 11-Month Low After Outsized Placebo Effect Torpedoes Schizophrenia Study Investor's Business Daily
2024-03-11 1:46:20 pm UPDATE 2-Acadia to stop trials of antipsychotic drug after it fails schizophrenia study Reuters
2024-03-11 1:13:10 pm Acadia Pharmaceuticals' schizophrenia drug fails in late-stage study Reuters
2024-03-11 1:5:0 pm Acadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia Business Wire
2024-03-01 3:39:14 am Analysts Have Made A Financial Statement On ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Yearly Report Simply Wall St.
2024-02-29 6:5:0 am Acadia Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference on March 6, 2024 Business Wire
   

Please consider a small donation if you think this website provides you with relevant information